Docusign (NASDAQ:DOCU - Get Free Report) will likely be issuing its Q2 2027 results after the market closes on Thursday, September 3rd. Analysts expect Docusign to post earnings of $1.08 per share and revenue of $867.2090 million for the quarter. Interested persons can find conference call details on the company's upcoming Q2 2027 earning summary page for the latest details on the call scheduled for Thursday, September 3, 2026 at 5:00 PM ET.
Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings data on Thursday, June 4th. The company reported $1.09 earnings per share for the quarter, topping analysts' consensus estimates of $0.99 by $0.10. Docusign had a net margin of 9.59% and a return on equity of 17.48%. The company had revenue of $830.24 million during the quarter, compared to analyst estimates of $824.71 million. During the same period in the prior year, the firm earned $0.90 earnings per share. The firm's revenue for the quarter was up 8.7% compared to the same quarter last year. On average, analysts expect Docusign to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Docusign Stock Performance
NASDAQ:DOCU opened at $59.33 on Thursday. The firm has a market cap of $11.33 billion, a P/E ratio of 38.53, a P/E/G ratio of 1.77 and a beta of 0.87. Docusign has a one year low of $40.16 and a one year high of $86.65. The firm has a 50-day simple moving average of $52.62 and a 200-day simple moving average of $48.93.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on the company. Citizens Jmp reiterated a "market outperform" rating and issued a $86.00 price target on shares of Docusign in a report on Tuesday, August 18th. BTIG Research dropped their price objective on Docusign from $70.00 to $60.00 and set a "buy" rating on the stock in a research report on Friday, June 5th. Citigroup reiterated a "market outperform" rating on shares of Docusign in a research note on Tuesday, August 18th. Wedbush decreased their price target on shares of Docusign from $60.00 to $58.00 and set a "neutral" rating for the company in a research report on Friday, June 5th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Docusign in a research report on Friday, June 5th. Four analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $60.27.
Check Out Our Latest Analysis on DOCU
Insider Buying and Selling at Docusign
In other news, insider James P. Shaughnessy sold 12,000 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $45.54, for a total transaction of $546,480.00. Following the completion of the sale, the insider owned 52,815 shares in the company, valued at approximately $2,405,195.10. This represents a 18.51% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Blake Jeffrey Grayson sold 15,000 shares of the firm's stock in a transaction on Friday, August 7th. The stock was sold at an average price of $60.00, for a total value of $900,000.00. Following the completion of the sale, the chief financial officer directly owned 126,429 shares of the company's stock, valued at $7,585,740. The trade was a 10.61% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 91,695 shares of company stock valued at $4,376,002. Corporate insiders own 0.59% of the company's stock.
Hedge Funds Weigh In On Docusign
Several hedge funds have recently modified their holdings of DOCU. State Street Corp boosted its stake in Docusign by 0.9% in the 4th quarter. State Street Corp now owns 8,193,805 shares of the company's stock worth $560,456,000 after purchasing an additional 77,008 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Docusign by 8.1% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,343,613 shares of the company's stock valued at $228,703,000 after purchasing an additional 251,639 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Docusign by 4.5% in the third quarter. Invesco Ltd. now owns 2,690,121 shares of the company's stock worth $193,931,000 after buying an additional 116,047 shares during the last quarter. Northern Trust Corp raised its holdings in shares of Docusign by 2.0% in the third quarter. Northern Trust Corp now owns 1,994,004 shares of the company's stock worth $143,748,000 after buying an additional 39,140 shares during the last quarter. Finally, Wellington Management Group LLP raised its holdings in shares of Docusign by 0.5% in the third quarter. Wellington Management Group LLP now owns 1,860,347 shares of the company's stock worth $134,112,000 after buying an additional 9,861 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company's stock.
About Docusign
(
Get Free Report)
DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report